EN DE
Watch CGN Nuclear Technology Development Co Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

CGN Nuclear Technology Development Co Ltd (000881) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of CGN Nuclear Technology Development Co Ltd stock ¥3.28, price ¥6.16, that is 46.8% below the price, quality 43 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials CN · ISIN CNE000000842

CN CGN Nuclear Technology Development Co Ltd logo Thin data Nov 5, 2026

CGN Nuclear Technology Development Co Ltd

000881 · SHE
Very expensive, weak quality

Our calculation puts a fair price 47% below what the stock costs today.

Low debt
Quality 43/100
Fair value ¥3.28 · Strongly overvalued (−46.8%)
Weak Growth (revenue 5y −3.5 %/yr in CNY)
Loss-making · -5.6% net margin (TTM)
Negative free cash flow
Trails peers (2/11)
Narrow moat 11/100 · thin data
Thin data
⟳ Cyclical
Watch CGN Nuclear Technology Development Co Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

¥11.38 ¥5.00 Fair Value ¥3.28 May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.

How to read this chart

60‑month range ¥5.00 – ¥11.38 · fair‑value band ¥1.94 – ¥4.60 · the ¥6.16 price screens above the ¥3.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.

Follow CGN Nuclear Technology Development Co in your weekly email

Every Wednesday you see whether CGN Nuclear Technology Development Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators.

Show moreShow less

The company is also involved in the provision of electron beam treatment of specialty waste; antibiotic residue treatment technology; pharmaceutical wastewater treatment technology; medical sewage and solid waste disposal; park sewage treatment; printing and dyeing wastewater treatment technology; coal chemical coking wastewater treatment technology; chemical wastewater treatment technology; domestic sewage treatment technology; and hazardous waste concentrate treatment services.

In addition, it provides new energy, irradiated, elastomer, and synthetic materials; modified polycarbonate and polyester, modified polypropylene, continuous fiber reinforced thermoplastic composites, and melt blown and radiation resistant polypropylene; and proton therapy tumor system equipment, raw materials and parts, radioactive medical isotopes, and hospital and nuclear drug products.

Further, the company engages in production and sale of plastic; and real estate development, as well as contracting, irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction businesses.

The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was founded in 1993 and is based in Shenzhen, China.

Stock analysis

CGN Nuclear Technology Development Co Ltd (000881) currently trades at ¥6.16, while our model-based Fair Value estimate is ¥3.28, 47% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 85/100, which puts the data coverage at low.

Scenario range: ¥1.94 (bear) to ¥4.60 (bull), the price of ¥6.16 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 43/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

CGN Nuclear Technology Development Co Ltd reported revenue of 5.6B CNY in FY2025 versus 8.0B CNY in FY2021, a compound −8.7%/yr. Reported net income was −287M CNY in FY2025.

Key figures

Market cap 5.8B CNY (≈ $874M) Small · P/S ratio 1.08 · EPS (TTM) ¥−0.3300 · Dividend yield 1.2% · Net margin −5.6% · Return on equity −6.3% · Return on assets (EBIT) −0.7% (5-year average) · Operating margin −3.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (low confidence).

What moves the price

The share trades about 36% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −47%, 000881 screens richer than that median.

Fair Value models

Bear ¥1.94 Fair Value ¥3.28 Bull ¥4.60
Price ¥6.16 · Downside -46.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA ¥0.9700 ¥1.64 ¥2.30 65
NCAV (Graham) ¥0.4600 ¥0.6900 ¥0.8600 55
All 2 models by family
Multiples
EV/EBITDA ¥0.9700 ¥1.64 ¥2.30 65
Asset-Based
NCAV (Graham) ¥0.4600 ¥0.6900 ¥0.8600 55

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 43/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 12
How much profit the company makes from its sales and capital
Quality Growth 46
Are margins and returns getting better?
Cashflow 9
Do the profits arrive as real cash?
Financial strength 56
Debt, balance sheet and risk of trouble
Investment 92
Does it invest with discipline instead of growing at any price?
Low Volatility 76
How calm the share price moves, does not count
Price momentum 24
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 8
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−10.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.5%
Start year 2020 (pandemic). Over 10 years: +10.0% a year
Revenue growth 30 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
4.6% (2020) → −1.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

000881 screens overvalued: fair value 47% below the price. Compare with Linde plc →

Compare CGN Nuclear Technology Development Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 727 stocks

Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 43 · Bottom 25%
Fair Value upside −46.8% · Below median
Profitability
Return on assets −2.8% · Bottom 25%
Net margin (12 months) −5.6% · Bottom 25%
Operating margin (12 months) −3.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −4.1% · Bottom 25%
Dividend yield (12 months) 1.2% · Below median
Balance sheet
Debt / equity 0.11× · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 1.16× · Cheaper than median
P/S (12 months) 1.06× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)0 · sector 67
PAST (return on equity)0 · sector 26
HEALTH (low debt)95 · sector 95
DIVIDEND (yield)24 · sector 30

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Nan Ya Plastics Corporation 1303 239.50 TWD 383.20 TWD +60% vs 000881
Wanhua Chemical Group 600309 ¥72.65 ¥68.03 −6% vs 000881
Linde plc LIN $515.25 $446.62 −13% vs 000881
PPG Industries, Inc PPG $122.38 $77.68 −37% vs 000881
DSM-Firmenich AG DSFIR CHF 100.50 CHF 57.70 −43% vs 000881
The Sherwin-Williams Company SHW $344.10 $146.37 −57% vs 000881
Givaudan SA GIVN CHF 4,054 CHF 1,554 −62% vs 000881
EMS-CHEMIE HOLDING AG EMSN CHF 848.50 CHF 284.63 −66% vs 000881
Ecolab Inc ECL $300.68 $96.56 −68% vs 000881
Air Products and Chemicals, Inc APD $304.84 $82.92 −73% vs 000881

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

CGN Nuclear Technology Development Co Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "CGN Nuclear Technology Development Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/000881

Frequently asked questions

Is CGN Nuclear Technology Development Co Ltd (000881) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of ¥3.28 versus a price of ¥6.16, about 47% lower (overvalued).
What is the fair value of 000881?
Our model-based fair value for CGN Nuclear Technology Development Co Ltd is ¥3.28 (as of Nov 5, 2026), built from audited fundamentals. The current price: ¥6.16.
What is the quality score of 000881?
CGN Nuclear Technology Development Co Ltd has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CGN Nuclear Technology Development Co Ltd (000881)?
Our model-based price target is the fair value of ¥3.28 (as of Nov 5, 2026) from 2 valuation models. Cautious scenario ¥1.94, optimistic scenario ¥4.60. It is a calculation from audited fundamentals, not an analyst target.
What is the CGN Nuclear Technology Development Co Ltd stock forecast for 2026?
Our models put fair value at ¥3.28, about 47% lower versus a price of ¥6.16 (overvalued). Cautious scenario ¥1.94, optimistic scenario ¥4.60. The calculation is refreshed regularly with new filings.
What is the revenue of CGN Nuclear Technology Development Co Ltd (000881)?
CGN Nuclear Technology Development Co Ltd reported trailing-twelve-month revenue of about 5.5B CNY (latest available figure, as of Nov 5, 2026).
Does CGN Nuclear Technology Development Co Ltd pay a dividend?
CGN Nuclear Technology Development Co Ltd currently shows a dividend yield of 1.18% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of CGN Nuclear Technology Development Co Ltd (000881)?
CGN Nuclear Technology Development Co Ltd has a dividend yield of 1.2%.
What is the intrinsic value of CGN Nuclear Technology Development Co Ltd (000881)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CGN Nuclear Technology Development Co Ltd it is ¥3.28 per share (as of Nov 5, 2026), against a price of ¥6.16. It is the blended result of 2 valuation models in 2 families (Multiples, Asset-Based).
Is CGN Nuclear Technology Development Co Ltd stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 000881 trades above its calculated fair value: price ¥6.16, fair value ¥3.28, a gap of about −47% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 000881?
No. The price is what the market pays today (¥6.16); the fair value is what the company's own numbers justify (¥3.28). For CGN Nuclear Technology Development Co Ltd the two are ¥2.88 per share apart. That gap is exactly why we show both numbers side by side.
How much is CGN Nuclear Technology Development Co Ltd worth?
The market values CGN Nuclear Technology Development Co Ltd at about 5.8B CNY (market capitalisation, as of Nov 5, 2026). Per share that is ¥6.16; our models calculate a fair value of ¥3.28 per share.
What do the bullish and bearish scenarios say about 000881?
Our models span a range for CGN Nuclear Technology Development Co Ltd: cautious scenario ¥1.94, base ¥3.28, optimistic ¥4.60 per share (as of Nov 5, 2026, price ¥6.16). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of CGN Nuclear Technology Development Co Ltd (000881)?
Balance-sheet figures for CGN Nuclear Technology Development Co Ltd (as of Nov 5, 2026): return on equity −6.3%, debt of 0.11 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is 000881 from its 52-week high?
CGN Nuclear Technology Development Co Ltd trades at ¥6.16, about 36% below its 52-week high of ¥9.59 and 5% above the low of ¥5.89 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥3.28 is for.
Which stocks are comparable to CGN Nuclear Technology Development Co Ltd?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CGN Nuclear Technology Development Co Ltd stock attractive at the current price?
The data as of Nov 5, 2026: price ¥6.16, calculated fair value ¥3.28 (−47%), Quality Score 43/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 000881 calculated?
We run CGN Nuclear Technology Development Co Ltd through 2 models from 2 families: Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of ¥3.28 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. CGN Nuclear Technology Development Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CGN Nuclear Technology Development Co Ltd (000881)?
The closing price on Nov 6, 2026 was ¥6.16. Our model-based fair value is ¥3.28, about 47% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CGN Nuclear Technology Development Co Ltd right now?
The price sits above even our optimistic bull case (¥4.60). The favourable scenario is already priced in. Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (¥1.94 to ¥4.60) leaves room in how you read the outcome.

Key figures of CGN Nuclear Technology Development Co Ltd

How large is the market capitalisation of CGN Nuclear Technology Development Co Ltd (000881)?
The market capitalisation of CGN Nuclear Technology Development Co Ltd is 5.8B CNY (≈ $874M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CGN Nuclear Technology Development Co Ltd (000881)?
The price-to-sales ratio of CGN Nuclear Technology Development Co Ltd is 1.08 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CGN Nuclear Technology Development Co Ltd (000881)?
Earnings per share at CGN Nuclear Technology Development Co Ltd are ¥−0.3300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of CGN Nuclear Technology Development Co Ltd (000881)?
The dividend yield of CGN Nuclear Technology Development Co Ltd is 1.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of CGN Nuclear Technology Development Co Ltd (000881)?
The net margin of CGN Nuclear Technology Development Co Ltd is −5.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CGN Nuclear Technology Development Co Ltd (000881)?
The return on equity (ROE) of CGN Nuclear Technology Development Co Ltd is −6.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CGN Nuclear Technology Development Co Ltd (000881)?
On an EBIT basis the return on assets of CGN Nuclear Technology Development Co Ltd is −0.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CGN Nuclear Technology Development Co Ltd (000881)?
The operating margin of CGN Nuclear Technology Development Co Ltd is −3.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CGN Nuclear Technology Development Co Ltd (000881)?
Revenue at CGN Nuclear Technology Development Co Ltd is growing −4.1% versus a year earlier (3y avg −7.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at CGN Nuclear Technology Development Co Ltd (000881)?
Earnings per share at CGN Nuclear Technology Development Co Ltd are growing −98.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does CGN Nuclear Technology Development Co Ltd (000881) generate?
The free cash flow of CGN Nuclear Technology Development Co Ltd is −211M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does CGN Nuclear Technology Development Co Ltd (000881) carry?
The net debt of CGN Nuclear Technology Development Co Ltd is 980M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch CGN Nuclear Technology Development Co Ltd in the live analysis

One click puts CGN Nuclear Technology Development Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.